AnaptysBio Inc. (ANAB) Declined -6.64% or -4.76 To Price $67.0 On Thursday


AnaptysBio Inc. (ANAB) declined -6.64% or -4.76 to $67.0. It is approximately 87965 shares traded, which is 33.91% compare to the average total volume 259404. The market cap of ANAB is $1.79 billion. The year to date change is 5.99%. The 52 week price range is from $54.26 to $133.89. Price of ANAB have changed 7.44% during last week. It have changed 10.90% over last month, -5.22% over last 3 months, -19.36% over last 6 months and -44.22% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ANAB is 67.22. It is 0.33% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for ANAB is 77.03. It is 14.97% above current price. The 52-week High is 133.89. It is 99.84% from the current price. The 52-week Low is 54.26. It is -19.01% from current price.

There are some statistics of ANAB. It is has market cap $1.79 billion. The share outstanding is 26.75 million. The average volume is 259404. The percent of top 15 Institution holding is 173.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ANAB is -17.14%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ANAB is -15.97%.


Tags:

Share this post